SCHEMBL29348556

SCHEMBL29348556

O=C1CCC(c2cccc(-c3ccc(N4CCOCC4=O)cc3)c2Cl)C(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 6/20 0.39
CRBN Q96SW2 6/20 0.39
CNR2 P34972 1/20 0.38
PTGS2 P35354 8/20 0.38
F10 P00742 3/20 0.36
CMA1 P23946 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348394 0.88 DDB1 (0.43) DDB1CRBN
SCHEMBL29348558 0.87 CNR2 (0.53) DDB1CRBNCNR2
SCHEMBL29348438 0.86 DDB1 (0.40) DDB1CRBNCNR2CMA1
SCHEMBL29348393 0.86 CNR2 (0.42) DDB1CRBNCNR2
SCHEMBL29348668 0.85 DDB1 (0.40) DDB1CRBNCNR2
SCHEMBL29348285 0.85 DDB1 (0.41) DDB1CRBNCNR2F10
SCHEMBL29348524 0.85 CRBN (0.44) DDB1CRBN
SCHEMBL29348552 0.83 CRBN (0.42) DDB1CRBN
SCHEMBL29348540 0.83 DDB1 (0.38) DDB1CRBNCNR2
SCHEMBL29348532 0.83 DDB1 (0.40) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed